By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – On-Q-ity today said that Laboratory Corporation of America will market the firm's circulating tumor cell platform to researchers in the biopharma industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.